Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

LI.c

Pericardial effusion (w/wo tamponade)

Publications

Siddiqui MA, Khan IA

Isoniazid-induced lupus erythematosus presenting with cardiac tamponade.

American journal of therapeutics 2002 Mar-Apr;9;163-5 — 2002 Mar-Apr — 163-5

Goldberg MJ, Husain M, Wajszczuk WJ, Rubenfire M

Procainamide-induced lupus erythematosus pericarditis encountered during coronary bypass sugery.

The American journal of medicine 1980 Jul;69;159-62 — 1980 Jul — 159-62

Mohindra SK, Udeani GO, Abrahamson D

Cardiac tamponade associated with drug-induced systemic lupus erythematosus.

Critical care medicine 1989 Sep;17;961-2 — 1989 Sep — 961-2

Ghose MK

Pericardial tamponade. A presenting manifestation of procainamide-induced lupus erythematosus.

The American journal of medicine 1975 Apr;58;581-5 — 1975 Apr — 581-5